Kuguyo Oppah, Matimba Alice, Tsikai Nomsa, Magwali Thulani, Madziyire Mugove, Gidiri Muchabayiwa, Dandara Collet, Nhachi Charles
University of Zimbabwe College of Health Sciences, Department of Clinical Pharmacology, Avondale, Harare, Zimbabwe.
University of Zimbabwe College of Health Sciences, Radiology Department, Harare, Zimbabwe.
Pan Afr Med J. 2017 Jul 21;27:215. doi: 10.11604/pamj.2017.27.215.12994. eCollection 2017.
Despite the wide-spread availability of cervical cancer prevention and screening programs in developed countries, the morbidity and mortality rates of cervical cancer in Zimbabwe are still very high. Limited resources as well as the high HIV prevalence are contributors to the high burden of cervical cancer. This paper aims to analyse the policies, frameworks and current practices in the management of cervical cancer in Zimbabwe.
A review of national documents and published literature on cervical cancer prevention, screening, treatment and knowledge in Zimbabwe was done. Informal interviews were conducted to assess the practices of cervical cancer management.
Through strategic collaboration, a pilot for the HPV vaccination program is underway. The VIAC national cervical cancer screening program is being adopted into the current healthcare system. With regards to the treatment of precancerous lesions we found that the "see and treat" program has been implemented in colposcopy clinics. In addition, there are two multidisciplinary cancer treatment clinics installed in two central public hospitals. The general knowledge and understanding of cervical cancer is poor in Zimbabwe.
Limitations in resources, infrastructure, manpower, delays in treatment and patient knowledge play a role in the high morbidity and mortality of cervical cancer in Zimbabwe. The Ministry of Health needs to increase funding to expedite the availability of HPV vaccine and screening programs. Community engagement initiatives to raise awareness on cervical cancer should be established to provide education on how to prevent the development of cervical cancer, as well as promote screening for early detection.
尽管在发达国家宫颈癌预防和筛查项目广泛可得,但津巴布韦宫颈癌的发病率和死亡率仍然很高。资源有限以及艾滋病毒高流行率是宫颈癌高负担的促成因素。本文旨在分析津巴布韦宫颈癌管理方面的政策、框架和当前做法。
对津巴布韦关于宫颈癌预防、筛查、治疗和知识的国家文件及已发表文献进行了综述。进行了非正式访谈以评估宫颈癌管理的实践情况。
通过战略合作,人乳头瘤病毒(HPV)疫苗接种项目的试点正在进行。视觉醋酸染色检查(VIAC)国家宫颈癌筛查项目正在被纳入当前的医疗保健系统。关于癌前病变的治疗,我们发现阴道镜检查诊所已实施“即看即治”项目。此外,两家中央公立医院设有两个多学科癌症治疗诊所。津巴布韦对宫颈癌的一般知识和了解较差。
资源、基础设施、人力方面的限制、治疗延误以及患者知识在津巴布韦宫颈癌的高发病率和高死亡率中起到了作用。卫生部需要增加资金,以加快HPV疫苗和筛查项目的可得性。应开展社区参与倡议,提高对宫颈癌的认识,提供关于如何预防宫颈癌发展的教育,并促进早期检测的筛查。